Stephen Matthews, the Denver physician accused of drugging and assaulting multiple women he met online, was convicted by a jury after more than three days of deliberation.
The Acuson Origin system includes advanced AI algorithms designed to assist users with the treatment of diagnostic, structural heart, vascular, electrophysiological and pediatric patients. It also comes packaged with a new 4D ICE catheter capable of multiplanar reconstruction imaging with or without the use of an electrocardiogram.
Fluoroscopy confirming no signs of paravalvular leak after a successful valve-in-valve caval valve implantation. Image courtesy of Jennifer von Stein, MD, et al. and JACC: Cardiovascular Interventions.
A care team in Germany has completed what may be the first structural heart procedure of its kind on a high-risk patient. It started as a straightforward heterotopic caval valve implantation, but then paravalvular leak resulted in a change of plans.
An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. The software was rolled out commercially in April 2023.
At its current rate, the number of clinical AI models cleared by the FDA will break 1,000 before the end of 2024. Cardiology continues to play a significant role in this ongoing trend.
Paradise Ultrasound image courtesy of Recor Medical.
Physicians using the Paradise Ultrasound Renal Denervation system from Recor Medical or Symplicity Spyral Renal Denervation system from Medtronic will soon be eligible for a much more significant reimbursement when treating Medicare patients in an inpatient setting.
Researchers hoped to gain a better understanding of the device's real-world impact by reviewing registry data from more than 97,000 U.S. patients. Overall, the Watchman FLX was linked to positive data and limited adverse events one year after treatment.
Cardiac CT scan for a pre-procedural assessment of a left atrial appendage occlusion (LAAO) procedure at Duly Healthcare in the Chicago suburbs. Cardiac CT use has increased the past few years and now CMS is looking to double what it pays for them in the 2025 HOPPS proposed rule. Photo by Dave Fornell
The agency is gathering feedback on a proposal to double the amount hospitals are paid for coronary computed tomography angiography, with the comment period ending Sept. 9.
The American College of Cardiology, American Heart Association and Heart Failure Society of America worked together on the updated document, adding three new performance measures and six new quality measures. They did not remove a single recommendation from the previous document published in 2020.
Structural heart specialists from The Christ Hospital. This team participated in a new EFS study focused on the J Valve from JC Medical. Image courtesy of JC Medical, a Genesis MedTech company, and The Christ Hospital.
The J Valve from JC Medical was linked to positive outcomes and “excellent” hemodynamic data after 30 days in an early feasibility study published in JACC: Cardiovascular Interventions. Researchers noted that the valve showed potential in patients with large aortic annuli, which represents an "unmet critical need" at this stage.
![Left atrial appendage occlusion (LAAO) with the Watchman FLX device from Boston Scientific is associated with positive outcomes and limited adverse events after one year, according to new findings published in Circulation: Cardiovascular Interventions.[1] Many prior Watchman FLX studies, including PINNACLE FLX, had focused on the device’s performance in a controlled setting. The study’s authors hoped to gain a better understanding of its real-world impact by reviewing registry data from more than 97,000 U.S](/sites/default/files/styles/top_stories/public/2024-08/screenshot_2024-08-12_at_11.35.13_am.png.webp?itok=5FeQeMFj)
